Study to Evaluate the Effects of Colesevelam on Insulin Sensitivity and ß-Cell Function in Subjects With Impaired Fasting Glucose (Prediabetes)

NCT00990184 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

21

Enrollment

OTHER

Sponsor class

Conditions

Impaired Fasting Glucose
Prediabetes

Interventions

DRUG: Colesevelam
OTHER: placebo

Sponsor

Seattle Institute for Biomedical and Clinical Research

Collaborators

[object Object]